Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Neoplasm Metastasis 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 116pembrolizumab 112Magnetic Resonance Spectroscopy 99Carboplatin 83Cyclophosphamide 70Biopsy 63Cisplatin 59Paclitaxel 56Bevacizumab 56Gemcitabine 48Nivolumab 45fludarabine 39Dexamethasone 37atezolizumab 36Rituximab 36Pemetrexed 36Fluorouracil 36Docetaxel 35Leucovorin 32Doxorubicin 31venetoclax 30Radiotherapy 30Oxaliplatin 29Capecitabine 29Temozolomide 27Prednisone 26Cetuximab 26130-nm albumin-bound paclitaxel 25Standard of Care 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Yttrium-90 × 30 days × Clear all
NCT04339036 2026-06-04

CapTemY90

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
70 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05195710 2026-05-26

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05620771 2026-05-26

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Northwestern University

Phase 2 Recruiting
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡